Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions

NCT ID: NCT00721435

Last Updated: 2017-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

183 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-04-30

Study Completion Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will evaluate and refine a breast screening and diagnosis device.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The device produces 3-D mammograms and ultrasound pictures of the breast at the same time and in the same position. This should help make sure that any area on a mammogram can be easily found in the ultrasound when using the new device. The 3-D mammograms should provide better visualization of the suspected lesion and improve diagnostic accuracy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Mass Cystic Benign Mass

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

3D Tomosynthesis & 3D Ultrasound for breast masses

Evaluate breast screening diagnostic device, 3D tomosynthesis. Assess utility of adding 3D ultrasound.

Group Type EXPERIMENTAL

3D Tomosynthesis and ultrasound imaging

Intervention Type PROCEDURE

3D tomosynthesis \& ultrasound imaging for scanning masses or healthy breast tissue

3D Tomosynthesis/ 3D Ultrasound for healthy subjects

Evaluate breast screening diagnostic device, 3D tomosynthesis. Assess utility of adding 3D ultrasound.

Group Type EXPERIMENTAL

3D Tomosynthesis and ultrasound imaging

Intervention Type PROCEDURE

3D tomosynthesis \& ultrasound imaging for scanning masses or healthy breast tissue

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

3D Tomosynthesis and ultrasound imaging

3D tomosynthesis \& ultrasound imaging for scanning masses or healthy breast tissue

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To participate in this research study you must be a female over the age of 25
* Have had a normal mammogram or are scheduled for a breast biopsy
* Have cysts or have been recommended to have a 6 month follow up mammogram after your biopsy.

Exclusion Criteria

* Male
* Under the age of 25
* Documented breast cancer
Minimum Eligible Age

25 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

University of Michigan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paul L. Carson Ph.D

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul L Carson, PHD

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Michigan

Ann Arbor, Michigan, United States

Site Status

University of Michigan

Ann Arbor, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01CA091713

Identifier Type: NIH

Identifier Source: secondary_id

View Link

HUM00045519 (2002-0584)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Using Diagnostic Tools to Stage Breast Cancer
NCT00367666 ACTIVE_NOT_RECRUITING NA
3D Ultrasound Breast Imaging
NCT04692818 RECRUITING NA